GlassScriptPhysician profile
Nisha Nayan Shah
NPI 1598150781
$3,785.89
in general payments reported to CMS, 2019-2025
29 companies · $792 in 2025
The $792 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $1,149 · 2021: $278 · 2022: $80.66 · 2023: $231 · 2024: $859 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,310.57 | 2021-2025 | Actishield, Bioskin, Graftjacket |
| Pylant Medical | $1,050.56 | 2020-2025 | |
| Smith+Nephew, INC. | $374.63 | 2019-2025 | Q-Fix, Hat-Trick, Stravix |
| Wright Medical Technology, INC. | $193.30 | 2019-2020 | |
| Depuy Synthes Sales INC. | $145.29 | 2021-2025 | Motoband, N/A, Motoband Cp |
| Tactile Systems Technology INC | $127.62 | 2019-2021 | |
| Orthofix Medical, INC. | $107.62 | 2020-2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Organogenesis INC. | $39.58 | 2024 | Affinity |
| Davol INC. | $29.39 | 2024 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $28.98 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $25.16 | 2024 | Activ.A.C., V.A.C. Dermatac |
| Mimedx Group, INC. | $23.65 | 2025 | |
| Cardiovascular Systems INC. | $23.43 | 2021 | |
| Treace Medical Concepts, INC. | $22.76 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $22.55 | 2025 | Nuzyra |
| Biowound Solutions, INC. | $21.42 | 2025 | Bio-Connekt |
| Averitas Pharma INC. | $21.22 | 2024 | Qutenza |
| Kerecis Limited | $19.74 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Normatec Industries, LP | $19.24 | 2019 | |
| Zyla Life Sciences, INC. | $18.32 | 2020 | |
| Reprise Biomedical, INC. | $17.68 | 2024 | Miro3d |
| Nabriva Therapeutics, Plc | $16.62 | 2022 | |
| Axogen | $13.84 | 2023 | Avance Nerve Graft |
| Amgen INC. | $13.29 | 2024 | Krystexxa |
| Arthrosurface Incorporated | $12.88 | 2020 | |
| Access Pro Medical, LLC | $12.72 | 2023 | Matriderm |
| Merck Sharp & Dohme LLC | $11.94 | 2019 | |
| Horizon Therapeutics Plc | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.